OTCPK:CLTS

Stock Analysis Report

Executive Summary

Earth Life Sciences Inc. focuses on training law enforcement, security, investigation, and protection for officers and individuals.


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Earth Life Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CLTS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

9.7%

CLTS

2.5%

US Professional Services

2.4%

US Market


1 Year Return

n/a

CLTS

-6.6%

US Professional Services

-10.0%

US Market

Return vs Industry: Insufficient data to determine how CLTS performed against the US Professional Services industry.

Return vs Market: Insufficient data to determine how CLTS performed against the US Market.


Shareholder returns

CLTSIndustryMarket
7 Day9.7%2.5%2.4%
30 Day19.3%-15.9%-11.0%
90 Day23.6%-18.5%-19.4%
1 Yearn/a-5.8%-6.6%-8.1%-10.0%
3 Year-38.2%-38.2%21.8%18.1%17.3%9.6%
5 Year-97.2%-97.2%37.7%30.5%36.1%21.1%

Price Volatility Vs. Market

How volatile is Earth Life Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Earth Life Sciences undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Earth Life Sciences is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Earth Life Sciences has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of CLTS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Earth Life Sciences regulatory filings here.
  • Explore potentially undervalued companies in the Commercial Services industry.

Future Growth

How is Earth Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.9%

Forecasted Commercial Services industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Earth Life Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Earth Life Sciences performed over the past 5 years?

-25.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CLTS is currently unprofitable.

Growing Profit Margin: CLTS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CLTS is unprofitable, and losses have increased over the past 5 years at a rate of -25.4% per year.

Accelerating Growth: Unable to compare CLTS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLTS is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (13.1%).


Return on Equity

High ROE: CLTS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Earth Life Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: CLTS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CLTS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CLTS has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CLTS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if CLTS has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CLTS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Earth Life Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CLTS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CLTS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CLTS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CLTS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CLTS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Angelo Marino (46yo)

no data

Tenure

Mr. Angelo M. Marino serves as the President & Chief Executive Officer of Earth Life Sciences Inc. Mr. Marino served as President of Earth Life Sciences Inc and served as its Secretary since October 1, 201 ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Earth Life Sciences Inc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Earth Life Sciences Inc
  • Ticker: CLTS
  • Exchange: OTCPK
  • Founded:
  • Industry: Human Resource and Employment Services
  • Sector: Commercial Services
  • Market Cap: US$2.975m
  • Shares outstanding: 464.82m
  • Website: https://www.earthlifesciences.net 

Location

  • Earth Life Sciences Inc
  • 1324 Chemin de Chambly
  • Longueuil
  • Quebec
  • J4J 3X3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLTSOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 2010

Biography

Earth Life Sciences Inc. focuses on training law enforcement, security, investigation, and protection for officers and individuals. It also has an option agreement to earn 100% interests in certain mineral concessions located in British Columbia. The company was formerly known as Canadian Tactical Training Academy Inc. and changed its name to Earth Life Sciences Inc. in June 2014. Earth Life Sciences Inc. is based in Longueil, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/07 10:38
End of Day Share Price2020/04/06 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.